Unlock instant, AI-driven research and patent intelligence for your innovation.

Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof

A kind of azole compound and compound technology, applied in the medical application of novel bisaryl tertiary amine azole compound, novel bis aryl tertiary amine azole compound and its pharmaceutically acceptable salt, achieving low cost and easy raw material The effect of obtaining and synthesizing is simple

Inactive Publication Date: 2013-03-20
SOUTHWEST UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there have been no reports in the field of biological activity of azole compounds containing bisaryl structures linked by nitrogen atoms and carbon chains. This field has the value of further research, development and application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof
  • Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof
  • Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1: Preparation of 2-chloro-N-(2-chloroethyl)-N-((4-chlorophenyl)(phenyl)methyl)ethylamine (compound 1 for short):

[0048]

[0049] Taking 4-chlorobenzophenone as the starting material, the intermediate 1-chloro-4-(chloro(phenyl)methyl)benzene is obtained through sodium borohydride reduction and thionyl chloride chlorination, and the intermediate is then subjected to Alkylation of diethanolamine nitrogen and chlorination of thionyl chloride to obtain the compound 1 It is a yellow liquid, and the total yield of the four-step reaction is 16.2%.

Embodiment 2

[0050] Example 2: N-(2-(1 H Preparation of -1,2,4-triazol-1-yl)ethyl)-2-chloro-N-((4-chlorophenyl)(phenylmethyl)ethylamine (compound 2 for short):

[0051]

[0052] Add 5 mL of acetonitrile, 0.18 g (1.32 mmol) of anhydrous potassium carbonate and 0.048 g (0.70 mmol) of 1,2,4-triazole into a 50 mL single-necked round bottom flask, react at 50 °C for 1 h, and cool to room temperature , 0.20 g (0.59 mmol) of 2-chloro-N-(2-chloroethyl)-N-((4-chlorophenyl)(phenyl)methyl)ethylamine was added under stirring. TLC detects to the end of the reaction, extracts by distillation under reduced pressure, concentrates, and obtains the compound by column chromatography 2 It is 0.063 g of yellow liquid, and the yield is 28.6%. IR (KBr) n: 3122 (Ar-H), 2945, 2832 (CH 2 ), 1543, 1507, 1490 (aryl skeleton, C=C), 1362, 1222 (C-N), 1091, 840, 770, 704 cm -1 ; 1 H NMR (300 MHz, CDCl 3 ): δ: 8.06 (s, 1H, triazole 5-H), 7.93 (s, 1H, triazole 3-H), 7.31 (q, 3H, J = 5.6 Hz, Ar H), 7.20 (q, 6...

Embodiment 3

[0053] Example 3: N-(2-(1H-imidazol-1-yl)ethyl)-2-chloro-N-((4-chlorophenyl)(phenyl)methyl)ethylamine (compound 3 for short) Preparation of:

[0054]

[0055] Add 10 mL of freshly evaporated tetrahydrofuran, 0.038 g (1.60 mmol) of NaH (1.60 mmol), and 0.095 g (1.40 mmol) of imidazole into a 50 mL three-neck round bottom flask, react at 50 °C for 1 h, cool to room temperature, and add 2-chloro- N-(2-Chloroethyl)-N-((4-chlorophenyl)(phenyl)methyl)ethylamine 0.40 g (1.17 mmol). TLC detects that until the reaction is completed, the solvent is evaporated under reduced pressure, extracted, dried over anhydrous sodium sulfate, and the compound is obtained by column chromatography 3 It is 0.096 g of colorless liquid, and the yield is 21.9%. 1 H NMR (300 MHz, CDCl 3 ) δ: 7.40 (s, 1H, imidazole 2-H), 7.26 ~ 7.15 (m, 9H, Ar H), 7.04 (s, 1H, imidazole 5-H), 6.76 (s, 1H, imidazole 4-H) , 4.83 (s, 1H, CH), 3.90 (s, 2H, imidazole CH 2 ), 3.36 (s, 2H, ClCH 2 ), 2.92 (d, J = 6.1 H...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to preparation for novel dual aryl tertiary amine azole compounds with biological activity and pharmacologically acceptable salts thereof The invention also relates to application of novel dual aryl tertiary amine azole compounds and pharmacologically acceptable salts thereof in anti infective medicaments and tumor resistance. The dual aryl tertiary amine azole compounds have quite valuable pharmacology activity in the aspects of bacteria resistance, fungus resistance and antitumor activity. The novel dual aryl tertiary amine azole compounds have general molecular formulas (I-II) shown in the specification, wherein the definitions of Ar1, Ar2, X, Im and Im3 are shown in the claims.

Description

technical field [0001] The present invention relates to the fields of organic chemistry and medicinal chemistry, in particular to novel bisaryl tertiary amine azole compounds and pharmaceutically acceptable salts thereof. The present invention relates to novel bisaryl tertiary amine azole compounds and pharmaceutically acceptable salts thereof. Salt preparation, biological activity. The invention also relates to the medical application of the novel bisaryl tertiary amine azole compound. Background technique [0002] Pathological changes caused by microorganisms such as fungi and bacterial infections are common and frequently occurring diseases, which are very harmful to human life. In recent decades, the widespread use of broad-spectrum antibiotics, hormones, immunosuppressants, and antitumor drugs has exacerbated the spread of fungal or bacterial diseases, especially deep fungal and bacterial infections have become the cause of death for cancer patients, AIDS patients and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D249/08C07D233/61C07D233/95C07D235/06C07D249/18A61K31/4196A61K31/417A61K31/4184A61K31/4192A61P31/04A61P31/10A61P35/00
Inventor 周成合张文泰
Owner SOUTHWEST UNIV